Viewing Study NCT01401868


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-02-02 @ 5:30 AM
Study NCT ID: NCT01401868
Status: COMPLETED
Last Update Posted: 2013-06-24
First Post: 2011-07-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
Sponsor: MEI Pharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module